AU4876997A - Treatment of iron overload disorders - Google Patents
Treatment of iron overload disordersInfo
- Publication number
- AU4876997A AU4876997A AU48769/97A AU4876997A AU4876997A AU 4876997 A AU4876997 A AU 4876997A AU 48769/97 A AU48769/97 A AU 48769/97A AU 4876997 A AU4876997 A AU 4876997A AU 4876997 A AU4876997 A AU 4876997A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- iron overload
- overload disorders
- disorders
- iron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74533596A | 1996-11-08 | 1996-11-08 | |
| US08745335 | 1996-11-08 | ||
| PCT/GB1997/003064 WO1998020905A2 (en) | 1996-11-08 | 1997-11-07 | Treatment of iron overload disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4876997A true AU4876997A (en) | 1998-06-03 |
Family
ID=24996276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU48769/97A Withdrawn AU4876997A (en) | 1996-11-08 | 1997-11-07 | Treatment of iron overload disorders |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU4876997A (en) |
| WO (1) | WO1998020905A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117547549A (en) * | 2023-11-09 | 2024-02-13 | 黑龙江八一农垦大学 | Preparation method of peritoneal dialysis solution and auxiliary scavenger suitable for canine ARF |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10112825A1 (en) * | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylation of active ingredients in aqueous solution |
| DE10209821A1 (en) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Coupling of proteins to a modified polysaccharide |
| DE10209822A1 (en) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Coupling of low molecular weight substances to a modified polysaccharide |
| WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| WO2013138101A2 (en) | 2012-03-16 | 2013-09-19 | Children's Medical Center Corporation | Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies |
| WO2015138916A1 (en) * | 2014-03-14 | 2015-09-17 | Yves Claude Nicolau | Myo-inositol trispyrophoshate as an anti-diabetic agent |
| CN114191425A (en) * | 2021-12-13 | 2022-03-18 | 亚宝药业集团股份有限公司 | Application of 2, 4-dihydroxy benzoic acid in food and medicine for treating iron overload diseases |
-
1997
- 1997-11-07 WO PCT/GB1997/003064 patent/WO1998020905A2/en active Application Filing
- 1997-11-07 AU AU48769/97A patent/AU4876997A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117547549A (en) * | 2023-11-09 | 2024-02-13 | 黑龙江八一农垦大学 | Preparation method of peritoneal dialysis solution and auxiliary scavenger suitable for canine ARF |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998020905A2 (en) | 1998-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| EP1143956A3 (en) | Compositions and methods for the treatment of anorectal disorders | |
| EP1063990A4 (en) | Therapy of estrogen-associated disorders | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| AU2972497A (en) | Treatment of oils | |
| IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
| AU2058697A (en) | Treatment of sleep disorders | |
| AU3552697A (en) | Novel treatment of leptine resistance | |
| AU1556497A (en) | Agents for the treatment and prevention of aids | |
| AU1742200A (en) | Prevention and treatment of amyloid-associated disorders | |
| AU1697197A (en) | Immunoconjugate for the treatment of aids | |
| AU4876997A (en) | Treatment of iron overload disorders | |
| AU1926597A (en) | Treatment of cocoa | |
| AU1853397A (en) | Treatment of pulmonary inflammation | |
| AU5446798A (en) | Compositions and methods for the treatment of gastrointestinal disorders | |
| AU3753500A (en) | Methods of treating fibrinogen-related disorders | |
| AU2619199A (en) | Treatment of waxes | |
| AU9082698A (en) | Treatment of inflammatory conditions | |
| AU1594397A (en) | Use of colostrum for the treatment of constipation | |
| AU7545998A (en) | Treatment of osteoporosis | |
| AU4310397A (en) | Treatment of waste | |
| AU4885397A (en) | Aids therapeutic composition | |
| AU2003204277A1 (en) | Treatment of hematologic disorders | |
| AUPM424794A0 (en) | Treatment of anorectal disorders | |
| AUPO108596A0 (en) | Treatment of obesity |